Family Meeting Study for End Stage Renal Disease
| Status: | Completed |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/20/2017 |
| Start Date: | July 2015 |
| End Date: | October 2016 |
Family Consultation for High-Risk Inpatients With End Stage Renal Disease: A Randomized Trial
A randomized clinical trial for patients with end stage renal disease in which a family
consultation condition is compared against a treatment as usual control condition on the
hospital readmissions after 1 month as the primary outcome variable.
consultation condition is compared against a treatment as usual control condition on the
hospital readmissions after 1 month as the primary outcome variable.
Patients hospitalized at Henry For Hospital who have end stage renal disease will complete
baseline questionnaires and be randomized into the experimental or control condition.
Patients randomized into the experimental condition will have a single family consultation
session before the patient is discharged. A trained, master's level therapist will conduct
the family consultation, which will use education, motivational interviewing, and other
techniques to help the family engage and support the patient's health needs. Patients in both
the experimental and control conditions will complete follow up questionnaires 1 month after
discharge. Investigators will conduct chart reviews of outcome data, including readmissions,
at 1, 3, and 6 months post-discharge.
baseline questionnaires and be randomized into the experimental or control condition.
Patients randomized into the experimental condition will have a single family consultation
session before the patient is discharged. A trained, master's level therapist will conduct
the family consultation, which will use education, motivational interviewing, and other
techniques to help the family engage and support the patient's health needs. Patients in both
the experimental and control conditions will complete follow up questionnaires 1 month after
discharge. Investigators will conduct chart reviews of outcome data, including readmissions,
at 1, 3, and 6 months post-discharge.
Inclusion Criteria:
- Hospitalized in inpatient Nephrology Unit at Henry Ford Hospital
- Has end-stage renal disease
- Willing and able to contact support person / family member about participating in the
study
Exclusion Criteria:
- Persistent Delirium
- Non-English speaking
We found this trial at
1
site
Detroit, Michigan 48202
Principal Investigator: Mark W Ketterer, Ph.D.
Phone: 240-381-1160
Click here to add this to my saved trials
